Sign in
Taking peopleNo phase

Effect of Pentoxifylline + CoQ10 vs CoQ10 Alone on Sperm Motility in Subfertile Men With Asthenozoospermia

Key facts

Who runs it
Mst.Sumyara Khatun
Where
Bangladesh1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
56 people, planned
Started
1 Oct 2025
Expected to end
1 Mar 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Coenzyme Q 10
  • Pentoxifylline 400 MG Oral Tablet
Record updated
26 November 2025

Who can take part

Age
20 years to 50 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Sub fertile men with asthenozoospermia(Total motility20% to less than 42%) according to WHO semen analysis,2021
  • Age 20-50 years

Who cannot take part

  • Drug, alcohol or substance abuse, psycho-sexual abnormalities
  • Drug, alcohol or substance abuse, psycho-sexual abnormalities
  • Any medical, endocrine and genetic disorders, history of chemotherapy or radiotherapy, genital infection, genital surgery
  • Any known hypersensitivity to xanthine related product, recent cerebral or retinal haemorrhage Severe oligoasthenoteratozoospermia
  • Any medical, endocrine and genetic disorders, history of chemotherapy or radiotherapy, genital infection, genital surgery
  • Any known hypersensitivity to xanthine related product, recent cerebral or retinal haemorrhage
  • Severe oligoasthenoteratozoospermia
  • Antioxidants supplmentation in the last 3 months
  • Antioxidants supplmentation in the last 3 months

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 50 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if drug Pentoxifylline plus Coenzyme Q10 work to treat asthenozoospermia in subfertile male. It will also learn about the safety of drug Pentoxifylline plus Coenzyme Q10. The main questions it aims to answer are:

Read full original descriptionShow less

Does drug Pentoxifylline plus Coenzyme Q10 increase the motility of sperm in participants? What medical problems do participants have when taking drug Pentoxifylline plus Coenzyme Q10 ? Researchers will compare drug Pentoxifylline plus Coenzyme Q10 combination to Coenzyme Q10 alone to see if drug Pentoxifylline plus Coenzyme Q10 combination works better.

Participants will:

Experimental Group:Pentoxifylline 400mg twice dailyand Coenzyme Q10 100mg twice daily for 3 months.

Comparator Group: Coenzyme Q10 100mg twice daily for 3 months Visit the clinic after three months of treatment for checkups and tests

The 2 groups in the trial

  • Experimental (PTX+ CoQ10)Treatment being tested

    Participants receive pentoxifylline 400mg orally twice daily plus Coenzyme Q10 100mg twice daily orally

    Treatment: Pentoxifylline 400 MG Oral Tablet

  • Active Comparator (Coenzyme Q10)Existing treatment, for comparison

    Participants receive Coenzyme Q10 100mg twice daily orally

    Treatment: Coenzyme Q 10

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Pentoxifylline Plus Coenzyme Q10 Combination Therapy Compared to Coenzyme Q10 Alone on Sperm Motility in Sub-fertile Male With Asthenozoospermia
Criteria questions
Built from NCT07252518, who can take part
Record updated
26 November 2025